Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 354301 - 354320 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (L01CX01) trabectedin | Trabectedin Teva 1 mg | 1 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 1 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaB.V. |
| Norway | (L01CX01) trabectedin | Yondelis 0,25 mg | 0.25 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 0,25 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Sarcoma | PharmaMArS.A. |
| Norway | (L01CX01) trabectedin | Yondelis 1 mg | 1 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 1 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Sarcoma | PharmaMArSA |
| Norway | (L01DB01) doxorubicin | Adriamycin 10 mg | 10 mg, Hetteglass, Pulver til injeksjonsvæske, oppløsning, 10 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | PfizerAS |
| Norway | (L01DB01) doxorubicin | Adriamycin 50 mg | 50 mg, Hetteglass, Pulver til injeksjonsvæske, oppløsning, 50 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | PfizerAS |
| Norway | (L01DB03) epirubicin | Epirubicin Accord 2 mg/ml | 5 ml, Hetteglass, Injeksjons-/infusjonsvæske, oppløsning, 2 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareB.V. |
| Norway | (L01DB03) epirubicin | Epirubicin Accord 2 mg/ml | 10 ml, Hetteglass, Injeksjons-/infusjonsvæske, oppløsning, 2 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareB.V. |
| Norway | (L01DB03) epirubicin | Epirubicin Accord 2 mg/ml | 50 ml, Hetteglass, Injeksjons-/infusjonsvæske, oppløsning, 2 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareB.V. |
| Norway | (L01DB03) epirubicin | Epirubicin Accord 2 mg/ml | 25 ml, Hetteglass, Injeksjons-/infusjonsvæske, oppløsning, 2 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareB.V. |
| Norway | (L01DC03) mitomycin | Mitomycin medac 1 mg/ml | 20 mg, Hetteglass, Pulver til intravesikaloppløsning/injeksjons-/infusjonsvæske, oppløsning, 1 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | Medac-GesellschaftfürklinischeSpezialpräparateGmbh-Wedel |
| Norway | (L01DC03) mitomycin | Mitomycin medac 1 mg/ml | 40 mg, Hetteglass, Pulver til intravesikaloppløsning/injeksjons-/infusjonsvæske, oppløsning, 1 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | Medac-GesellschaftfürklinischeSpezialpräparateGmbh-Wedel |
| Norway | (L01EJ01) ruxolitinib (adm: O) | Jakavi 15 mg | 56 stk, Blisterpakning, Tablett, 15 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | OrifarmAS |
| Norway | (L01EJ01) ruxolitinib (adm: O) | Jakavi 20 mg | 56 stk, Blisterpakning, Tablett, 20 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | OrifarmAS |
| Norway | (L01EX04) vandetanib (adm: O) | Caprelsa 100 mg | 30 stk, Blisterpakning, Tablett, filmdrasjert, 100 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | SanofiB.V. |
| Norway | (L01EX04) vandetanib (adm: O) | Caprelsa 300 mg | 30 stk, Blisterpakning, Tablett, filmdrasjert, 300 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | SanofiB.V. |
| Norway | (L01EX07) cabozantinib (adm: O) | Cometriq <multi> |
28 stk, Blisterpakning,, |
Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | IpsenPharma |
| Norway | (L01EX07) cabozantinib (adm: O) | Cometriq <multi> |
28 stk, Blisterpakning,, |
Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | IpsenPharma |
| Norway | (L01FD01) trastuzumab | Herceptin 150 mg | 150 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 150 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | RocheRegistrationGmbH |
| Norway | (L01FD01) trastuzumab | Ogivri 150 mg | 150 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 150 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BiosimilarCollaborationsIrelandLimited |
| Norway | (L01FD01) trastuzumab | Zercepac 150 mg | 150 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 150 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U. |
Pages
